WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone vs Hybrid Ablation With PVI Plus Catheter Ablation

Not Applicable

Withdrawn

Conditions: Persistent Atrial Fibrillation

Interventions: Device: Medtronic Cryoballoon
Device: nContact
Device: Thermocool Catheter

First Posted Date: 2015-01-26

Last Posted Date: 2024-10-03

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT02344394

Locations: 🇺🇸
Aurora Health Care, St. Luke's Medical Center, Milwaukee, Wisconsin, United States

A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)

Phase 2

Terminated

Conditions: Cancer of Brain and Nervous System

Interventions: Device: NovoTTF100A
Drug: Bevacizumab
Drug: Temozolomide

First Posted Date: 2015-01-22

Last Posted Date: 2022-11-03

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 13

Registration Number: NCT02343549

Locations: 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States

Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 2

Terminated

Conditions: Recurrent Adult Acute Myeloid Leukemia

Interventions: Drug: Vincristine Sulfate Liposome
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-01-13

Last Posted Date: 2019-08-14

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 5

Registration Number: NCT02337478

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Botanical Oils Study to Determine Genetic Differences in the Way Your Body Processes Fats in Edible Oils

Not Applicable

Completed

Conditions: Genetic Differences of Lipid Metabolism/Healthy Subjects

Interventions: Dietary Supplement: soybean oil and borage oil

First Posted Date: 2015-01-13

Last Posted Date: 2018-08-14

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 66

Registration Number: NCT02337231

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

Role of Hyaluronic Acid in Causing Cancer Stem Cell Growth in the Bones of Patients With Breast Cancer

Withdrawn

Conditions: Breast Carcinoma Metastatic to the Bone
Stage IV Breast Cancer

Interventions: Other: Cytology Specimen Collection Procedure
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-01-06

Last Posted Date: 2018-07-02

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT02331212

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation

Completed

Conditions: Cerebral Hemorrhage

First Posted Date: 2015-01-06

Last Posted Date: 2024-10-03

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 16

Registration Number: NCT02331719

Locations: 🇺🇸
University Of Arkansas of Medical Sciences, Little Rock, Arkansas, United States
🇺🇸
University of Colorado, Aurora, Colorado, United States
🇺🇸
Riverside Methodist Hospital (OhioHealth), Columbus, Ohio, United States

and more 5 locations

LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: Carboplatin
Drug: Abraxane

First Posted Date: 2014-12-31

Last Posted Date: 2022-08-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 11

Registration Number: NCT02328105

Locations: 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States

Proving Hemodilution in a Human Model for Class I Hemorrhage

Not Applicable

Completed

Conditions: Wounds and Injuries
Shock
Hemodilution
Hemorrhage

Interventions: Other: lactated ringers
Other: normal saline

First Posted Date: 2014-12-17

Last Posted Date: 2022-04-21

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 165

Registration Number: NCT02318355

Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies

Completed

Conditions: Leukemia
Lymphoma

Interventions: Drug: Loratadine

First Posted Date: 2014-12-03

Last Posted Date: 2018-07-03

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 61

Registration Number: NCT02305979

Locations: 🇺🇸
Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States

Qsymia as an Adjunct to Surgical Therapy in the Superobese

Phase 2

Completed

Conditions: Metabolic Surgery
Bariatric Surgery Procedures
Obesity
Weight Loss

Interventions: Drug: Phentermine/topiramate
Other: low calorie diet

First Posted Date: 2014-11-25

Last Posted Date: 2019-09-04

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 25

Registration Number: NCT02301416

Locations: 🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy